A Phase II Clinical Trial of Fruquintinib as Third Line Treatment in Advanced Pancreatic Cancer

Clinical trial NCT05257122 · UNKNOWN

Trial details

NCT number: NCT05257122
Sponsor: Fudan University
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced Pancreatic Carcinoma

Start date: 2022-02-01
Primary completion: 2023-09-01
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.